Ohio Third Frontier Fund puts $1M into advanced next-generation medical device company
EndoSphere Inc. today announced that the Innovation Ohio Loan Fund (IOLF) has awarded $1 million to support EndoSphere’s platform of noninvasive, endoscopically-implantable devices that treat metabolic diseases including obesity and type 2 diabetes.